Health
SARS-CoV-2 evolves antibody resistance in immunocompromised patient – News-Medical.Net
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found…
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.
The SARS-CoV-2 virus is the agent responsible for the coronavirus 2019 (COVID-19) pandemic that continues to pose a significant threat to global public health and the worldwide economy.
The team’s analysis…
-
Noosa News22 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News23 hours agoYoung voices shape Sunshine Coast’s future
-
Business23 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News20 hours agoStar Entertainment signs $300m lifeline deal with US gaming giant Bally’s